Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 1
Submit an article Journal homepage
4
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Tilt training and pacing: a report on 9 patients with neurally mediated syncope

Tony ReybrouckDepartments of Cardiology and Cardiovascular Rehabilitation, Gasthuisberg University Hospital Leuven and Department of Rehabilitation Sciences, K.U.Leuven, Leuven, Belgium.Correspondence[email protected]
, PhD,
Hein HeidbÜchelDepartments of Cardiology and Cardiovascular Rehabilitation, Gasthuisberg University Hospital Leuven and Department of Rehabilitation Sciences, K.U.Leuven, Leuven, Belgium.
, MD, PhD;,
Rik WillemsDepartments of Cardiology and Cardiovascular Rehabilitation, Gasthuisberg University Hospital Leuven and Department of Rehabilitation Sciences, K.U.Leuven, Leuven, Belgium.
, MD, PhD &
Hugo EctorDepartments of Cardiology and Cardiovascular Rehabilitation, Gasthuisberg University Hospital Leuven and Department of Rehabilitation Sciences, K.U.Leuven, Leuven, Belgium.
, MD, PhD
Pages 3-7 | Received 29 Sep 2009, Accepted 02 Oct 2009, Published online: 23 May 2017

References

  • Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P. Giani P, Moya A. Dual chamber pacing in the treatment of neutrally mediated tilt-positive cardio-inhibitory syncope. Circulation 2000; 102: 294–5.
  • Verheyden, B, Ector H, Aubert A, Reybrouck T. Tilt train-ing increases the vasoconstrictor reserve in patients with neurally mediated syncope evoked by head-up tilt testing. Eur Heart J2008; 298: 523–30.
  • Connolly SJ, Sheldon R, Thorpe KE, Roberts RX, Ellen-bogen KA, Wilkoff BL, Morino C, Gent M, VPS II Inves-tigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 2003; 289: 2224–9.
  • Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Block Thomsen PE, van Dijk JC, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny R, Kulakowski P, Masotti G, Moya A, Raviele A, Sutton R, Theodorakis G, Ungar A, Wieling W Guidelines on management (diagnosis and Treatment) of syncope. Eur Heart J 2004; 25: 2054–72.
  • Vahanian A, Auricchio A, Box J, Ceconi C, Dean V, Despres C, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, McGregor K, Popescu B, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky, Zamorano Gomez JL. ESC Committee for practice guidelines (CPG2006-2008). Lippincott Williams & Wilkins, London, 2008.
  • Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal Pacemaker Study (VPS). A random-ized trial of permanent pacing for the prevention of vaso-vagal syncope. J Am Coll Cardiol 1999; 33: 16–20.
  • Ammirati F, Coivicchi F, Santini M. Syncope Diagnosis and Treatment Study Investigators. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multicenter, randomized, controlled trial. Circulation 2001; 104; 52–7.
  • Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W, Andresen D, Benditt D, Vardas P (ISSUE 2 Group). Early application of an implantable loop recorder allows specific therapy in patients with recurrent neurally mediated syncope. Eur Heart J 2006; 27: 1085–92.
  • Ector H, Willems R, Heidbiichel H, Reybrouck T. Repeated tilt testing in patients with tilt-positive neurally mediated syncope. Europace 2005; 7: 628–33.
  • Foglia-Manzillo G, Giada F, Gagglioli G, Bartoletti A, Loui G, Dinelli M, Del Rosso A, Santorone M, Raviele A, Brignole M. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace 2004; 6: 199–204.
  • Reybrouck T, Ector H. Tilt training: a new challenge in the treatment of neurally mediated syncope. Acta Cardiol 2006; 61: 183–9.
  • Zeng H, Ge K, Zhang W, Wang G, Guo L. The effect of orthostatic training in the prevention of vasovagal syncope and its influencing factors. Int Heart J2008; 49: 707–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.